Groundwork BioAg and Biofloral announced the commercial launch of DynoMyco C mycorrhizal inoculants in Canada. "Based on 30 years of joint R&D by Groundwork BioAg and Israel's Volcani Center, DynoMyco C is a potent mycorrhizal inoculant, ideally suited for cannabis cultivation," the team with the company explains. "It contains 2,500 endomycorrhizal propagules per gram, and is registered for commercial use by the Canadian Food Inspection Agency (CFIA) – setting it apart from other commercially available products."
"Since full legalization took effect back in 2018, we set our sights on the Canadian cannabis market," states Ari Singer, DynoMyco Sales Manager at Groundwork BioAg. "Estimated at C$8B, the Canadian cannabis market is likely the second largest in the world, after the US. Biofloral, perhaps the largest player in this market, was a natural fit for us, the perfect partner for penetrating this lucrative market."
"Our customer base includes over 250 grow shops, 180 licensed producers (LPs) and micro-LPs, and growers with Access to Cannabis for Medical Purposes Regulations (ACMPRs). Our customers have seen significant benefits by applying DynoMyco C over several growth cycles already," adds Jason Stanley, Sales Director at Biofloral. "DynoMyco C consistently and significantly increases crop yields and cannabinoid content, including THC. At the same time, it reduces transplant stress, and even shortens the cultivation cycle. Growers are getting more flower per square meter with the simple addition of these beneficial fungi. It's a true game changer for home growers and large-scale facilities alike."